Clinical Trials Browser

Phase 1/2 × HLX07 × 90 days × Clear all

NCT07358585 2026-01-22

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Colonic Neoplasms